immunosuppressantsGlucocorticoidsSLEhydroxychloroquineDiabetes mellitusRSR ltdGAD AbZnT8 AbSLEDAI-2K
…elated to a specific subtype of rheumatic disease or the use of immunosuppressants. Further research is needed to clarify this finding.…
8articles mentioning treatments
11treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: immunosuppressants ×
immunosuppressants
This treatment is selected. Its supporting articles are shown below.
Articles mentioning immunosuppressants
8 articles · page 1 of 1immunosuppressantsHealth Assessment Questionnairemycophenolate mofetilDiffuse cutaneous systemic sclerosis (dcSSc)cyclophosphamideCYCATGdcSSc
…ity. Several treatments aim to modify disease course, including immunosuppressants and autologous hematopoietic stem cell transplantation (HSCT). …
immunosuppressantspyridostigminesalbutamolseronegative myasthenia gravisCongenital myasthenic syndromesCMS
…he diagnosis of DOK7 CMS. Both patients improved after stopping immunosuppressants and pyridostigmine and starting salbutamol. These cases highlig…
immunosuppressantsrituximabSjögren’s syndromeSLESystemic Lupus Erythematosusmycophenolate mofetilGCHCQanifrolumab
…was difficult to treat. The patient was treated with biologics, immunosuppressants (IS), and glucocorticosteroids (GC).Methods In August 2025, a 3…
immunosuppressantsCLA-IGA-RCutaneous lupus erythematosusantimalarialsBiogentopical corticosteroidssystemic lupus erythematosusCLEErythema
…ded antimalarials (69.7%), topical corticosteroids (50.8%), and immunosuppressants (37.7%). The majority were overweight or obese; most had never …
csDMARDsimmunosuppressantsconventional synthetic disease-modifying antirheumatic drugssystemic lupus erythematosusleflunomidecyclosporin
…of the disease characteristics that had warranted initiation of csDMARDs, we used Directed Acyclic Graphs to construct a causal model fo…
plasmapheresisimmunosuppressantsrituximabmultiple sclerosisMSNeuromyelitis optica spectrum disorder (NMOSD)NMOSDLongitudinal extensive transverse myelitis
…ivity, complicated by paraplegia and dysautonomia, managed with plasmapheresis, rituximab, and immunosuppressants. Functional outcomes varied,…
anti-rejection medicationimmunosuppressantsanti-rejection medicationstacrolimuskidney transplant recipientskidney transplant centresTPE
…ves, with an implementation rate of 93.5% (29/31). The topic of anti-rejection medication was consistently addressed, with only one centre not providing …